This announcement is a separate document:
泓博医药：中信证券股份有限公司关于上海泓博智源医药股份有限公司使用剩余超募资金永久补充流动资金的核查意见
Hongbo Pharmaceutical: CITIC Securities Co., Ltd.'s verification opinion on the use of surplus overraised capital by Shanghai Hongbo Zhiyuan Pharmaceutical Co., Ltd. to permanently supplement working capital
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.